menu
    • menu

    Company profile for Scholar Rock

    NEW Drugs in Dev: 4
    Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

    Virtual Booth

    Contact Supplier

    Lupin Manufacturing Solutions – delivering high-quality APIs & end-to-end CDMO services for faster, cost-effective drug development.

    Virtual Booth

    Contact Supplier

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Egis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-2026-02-09

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Scholar Rock is discovering and developing a pipeline of innovative new medicines to treat a range of serious diseases with high unmet medical need, including neuromuscular disorders, cancer, fibrosis, and anemia. By focusing on the newly elucidated biology of growth factor activation, Scholar Rock has developed new insights which allow us to selectively target growth factors in the disease microenvironment, to achieve ther...
    Scholar Rock is discovering and developing a pipeline of innovative new medicines to treat a range of serious diseases with high unmet medical need, including neuromuscular disorders, cancer, fibrosis, and anemia. By focusing on the newly elucidated biology of growth factor activation, Scholar Rock has developed new insights which allow us to selectively target growth factors in the disease microenvironment, to achieve therapeutic effects specifically at the source of disease.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Scholar RockUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    620 Memorial Drive, 2nd Floor Cambridge, MA 02139
    Telephone
    Telephone
    (857) 259-3860
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://scholarrock.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Natural Product Expo West

    Natural Product Expo West

    Not Confirmed

    envelop Contact Supplier

    Natural Product Expo West

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Scholar Rock To Present At Upcoming Investor Conferences
    Scholar Rock To Present At Upcoming Investor Conferences

    18 Feb 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260218128585/en/Scholar-Rock-to-Present-at-Upcoming-Investor-Conferences

    BUSINESSWIRE
    18 Feb 2026
    Share Share
    Scholar Rock Issues Employee Grants Per Nasdaq LR 5635(C)(4)
    Scholar Rock Issues Employee Grants Per Nasdaq LR 5635(C)(4)

    13 Feb 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260213692517/en/Scholar-Rock-Reports-New-Employee-Inducement-Grants-Under-Nasdaq-Listing-Rule-5635c4

    BUSINESSWIRE
    13 Feb 2026
    Share Share
    Scholar Rock To Release 2025 Financial Results On March 3, 2026
    Scholar Rock To Release 2025 Financial Results On March 3, 2026

    10 Feb 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260209377736/en/Scholar-Rock-to-Report-Fourth-Quarter-and-Full-Year-2025-Financial-Results-on-March-3-2026

    BUSINESSWIRE
    10 Feb 2026
    Share Share
    Scholar Rock Discloses Employee Grants Per Nasdaq LR 5635(C)(4)
    Scholar Rock Discloses Employee Grants Per Nasdaq LR 5635(C)(4)

    16 Jan 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260116642780/en/Scholar-Rock-Reports-New-Employee-Inducement-Grants-Under-Nasdaq-Listing-Rule-5635c4

    BUSINESSWIRE
    16 Jan 2026
    Share Share
    Scholar Rock Highlights 2026 Strategic Priorities
    Scholar Rock Highlights 2026 Strategic Priorities

    12 Jan 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260112295221/en/Scholar-Rock-Highlights-2026-Strategic-Priorities

    BUSINESSWIRE
    12 Jan 2026
    Share Share
    Scholar Rock Presents At 44Th J.P. Morgan Healthcare Conference
    Scholar Rock Presents At 44Th J.P. Morgan Healthcare Conference

    05 Jan 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260105255161/en/Scholar-Rock-to-Present-at-the-44th-Annual-J.P.-Morgan-Healthcare-Conference

    BUSINESSWIRE
    05 Jan 2026
    Share Share

    Inspections and registrations

    Upload your audits for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search